MyAmyloidosisTeam

Since Attruby was just approved by the FDA in 2024, there isn't much real-world data yet about people using both medications. Both medications work in similar ways by stabilizing the transthyretin protein to prevent harmful amyloid deposits. While both medications are approved to treat cardiomyopathy in amyloidosis, they Show Full Answer

Since Attruby was just approved by the FDA in 2024, there isn't much real-world data yet about people using both medications. Both medications work in similar ways by stabilizing the transthyretin protein to prevent harmful amyloid deposits. While both medications are approved to treat cardiomyopathy in amyloidosis, they have different side effect profiles. Attruby's common side effects include diarrhea and mild stomach pain. With Vyndamax (tafamidis), patients should watch for signs of allergic reactions like trouble swallowing, hives, chest tightness, or fast heartbeat.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

8 Amyloidosis Treatments and Their Side Effects

Is Cardiac Amyloidosis Curable?